portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:

 Shenzhen Hepalink Pharma. Co., Ltd. to Set up Joint Venture
 
CreateTime:2011-08-22     Source:Reuters Editor:hangmei
Text Size:       
 
Related Company：
Shenzhen Hepalink Pharmaceutical Co., Ltd.(002399.SZ)

Thursday, 18 Aug 2011 08:00pm EDT

Shenzhen Hepalink Pharma. Co., Ltd. (002399.SZ )announced that it will invest RMB 20 million to set up a joint venture with Dr. Liu Liping, with each to hold a 57.143% and a 42.857% stake. The joint venture will be with a registered capital of RMB 35 million and be engaged in the research and development of polypeptide drugs.
Related Reports
China Independent Clinical Laboratory Industry Report, 2019-2025
Global and China Industrial Enzyme Industry Report, 2014-2017
About RIC | Copyright | Contact Us | Privacy policy | Buy Reports | Member Service | Mailing List
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1